Patient Square Capital LP Q3 2025 Filing
Filed November 10, 2025
Portfolio Value
$373.9B
Holdings
24
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ROIVROIVANT SCIENCES LTD | 12,480,000 | $188.8B | 50.51% | |
| 2 | IM8NINSMED INC | 326,400 | $47.0B | 12.57% | |
| 3 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,011,839 | $14.4B | 3.85% | |
| 4 | ABVXABIVAX SA | 151,833 | $12.9B | 3.45% | |
| 5 | CDTXCIDARA THERAPEUTICS INC | 121,000 | $11.6B | 3.10% | |
| 6 | ARGXARGENX SE | 15,500 | $11.4B | 3.06% | |
| 7 | LQDALIQUIDIA CORPORATION | 400,000 | $9.1B | 2.43% | |
| 8 | PHVSPHARVARIS N V | 345,381 | $8.6B | 2.30% | |
| 9 | OCULOCULAR THERAPEUTIX INC | 715,000 | $8.4B | 2.24% | |
| 10 | MIRMMIRUM PHARMACEUTICALS INC | 104,262 | $7.6B | 2.04% | |
| 11 | AGIOAGIOS PHARMACEUTICALS INC | 133,827 | $5.4B | 1.44% | |
| 12 | KYMRKYMERA THERAPEUTICS INC | 92,592 | $5.2B | 1.40% | |
| 13 | ELVNENLIVEN THERAPEUTICS INC | 250,838 | $5.1B | 1.37% | |
| 14 | CELCCELCUITY INC | 100,000 | $4.9B | 1.32% | |
| 15 | DNTHDIANTHUS THERAPEUTICS INC | 125,000 | $4.9B | 1.32% | |
| 16 | IRONDISC MEDICINE INC | 74,000 | $4.9B | 1.31% | |
| 17 | QUREUNIQURE NV | 75,000 | $4.4B | 1.17% | |
| 18 | AMLXAMYLYX PHARMACEUTICALS INC | 316,312 | $4.3B | 1.15% | |
| 19 | NRIXNURIX THERAPEUTICS INC | 437,237 | $4.0B | 1.08% | |
| 20 | ALLOALLOGENE THERAPEUTICS INC | 2,981,396 | $3.7B | 0.99% | |
| 21 | ASMBASSEMBLY BIOSCIENCES INC | 135,182 | $3.5B | 0.93% | |
| 22 | AVTXAVALO THERAPEUTICS INC | 100,000 | $1.3B | 0.34% | |
| 23 | CATXPERSPECTIVE THERAPEUTICS INC | 349,323 | $1.2B | 0.32% | |
| 24 | GONGERON CORP | 845,000 | $1.2B | 0.31% |